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Background: Measurement of outcomes after major abdominal surgery has traditionally focused on mortality,
however the low incidence in elective surgery makes this measure a poor comparator. The Postoperative Morbidity
Survey (POMS) prospectively assesses short-term morbidity, and may have clinical utility both as a core outcome
measure in clinical trials and quality of care. The POMS has been shown to be a valid outcome measure in a mixed
surgical population, however it has not been studied in patients undergoing major abdominal surgery. This study
assessed the inter-rater reliability and validity of the POMS in patients undergoing major abdominal surgery.
Methods: Patients undergoing elective major abdominal surgery were visited on postoperative day 1 until
discharge by two novice observers who administered the POMS in order to assess inter-rater reliability. Subjects
who had previously had the POMS performed prospectively on postoperative days 3 and 5 were identified from a
database. The pattern and prevalence of morbidity was analyzed against hospital length of stay (LOS) in order to
validate the POMS in this patient group.
Results: Fifty one patients were recruited to the inter-rater reliability study giving a total of 263 POMS assessments.
Inter-rater reliability showed a 97.7% agreement with a κ coefficient of 0.912 (95% CI: 0.842 to 0.982). On domain
analysis percentage agreement was lowest in the gastrointestinal domain (87.5%), whilst correlation was lowest in
the wound (κ: 0.04; 95% CI: −1.0 to 1.0) and hematological domains (κ: 0.378; 95% CI: 0.035 to 0.722). All other
domains showed at least substantial agreement. POMS assessments were analyzed for postoperative days 3
(n = 258) and 5 (n = 362). The absence or presence of morbidity as measured by the POMS was associated with a
hospital LOS of 6 (IQR: 4 to 7) vs. 11 (IQR: 8 to 15) days on postoperative day 3 (P <0.0001), and 7 (IQR: 6 to 10) vs.
13 (IQR: 9 to 19) days on postoperative day 5 (P <0.0001). The presence of any morbidity on postoperative day 5
conferred an odds ratio for a prolonged hospital LOS of 11.9 (95% CI: 5.02 to 11.92).
Conclusions: This study shows that the POMS is both a reliable and valid measure of short-term postoperative
morbidity in patients undergoing major abdominal surgery.
Keywords: Major surgery, Morbidity, Postoperative morbidity survey, Postoperative outcomeBackground
Measurement of patient outcomes after major abdominal
surgery has traditionally focused on mortality; however, the
relatively low event rate for the majority of elective surgical
procedures makes this a poor discriminator of both the
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reproduction in any medium, provided the orinterventions. Although absolute in terms of an outcome
measure, the use of mortality as a clinical end-point is not
without its discrepancies. The temporal variation in
reporting, ranging from in hospital mortality to up to 1 year
mortality, means that it is a difficult and poor comparator,
and the loss of patients to long-term follow-up is an add-
itional confounder. It has been suggested that 30-day mor-
tality may underestimate short-term patient outcomes
following major abdominal surgery, with a significant in-
crease in mortality seen at 90 days [1].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 The Postoperative Morbidity Survey (POMS)
showing morbidity types, definitions and source data
Morbidity type Criteria Source data
Pulmonary De novo requirement for
supplemental oxygen or
other respiratory support




Infectious Currently on antibiotics or




Renal Presence of oliguria
(<500 mL/day), increased
serum creatinine (>30%
from baseline value), or
urinary catheter in place




Gastrointestinal Unable to tolerate an
enteral diet (either by
mouth or feeding tube)





Cardiovascular Diagnostic test or therapy
in last 24 hrs for any of
the following reasons: de
novo myocardial infarction
or ischemia, hypotension
(requiring drug therapy or







Neurological Presence of a de novo




Wound complications Wound dehiscence
requiring surgical
exploration or drainage or
pus from the wound
Note review
Pathology results
Hematological Requirement for any of
the following within last
24 hrs: blood, platelets,
fresh frozen plasma or
cryoprecipitate
Fluid balance chart
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surgery, particularly in the higher risk patient. The import-
ance of complications in the immediate postoperative
period is clear, however perioperative complications may
have long-term implications for both the quality and
quantity of an individual’s life with an associated reduction
in median survival [1,2]. The measurement and reporting
of outcomes following major surgery is a fundamental
process to improving the quality and safety of care that a
health system provides, both in terms of the health frame-
work and delivery of care by institutions and the individ-
ual clinicians themselves [3,4]. It is theoretically desirable
to have a core set of outcomes measured and reported
as a minimum in clinical research, allowing differing
interventions to be compared and contrasted with greater
ease and reducing the risk of outcome reporting bias.
The postoperative morbidity survey (POMS) is a nine-
domain system that prospectively identifies short-term
mortality after surgery [5]. For each of the nine domains
morbidity is recorded on the presence or absence of preset
criteria and it appears to accurately describe the pattern
and prevalence of morbidity in the postoperative setting.
The purpose of this study was firstly to ascertain
whether it is feasible to use the POMS as a core outcome
measure for reporting in clinical trials by assessing the
inter-rater reliability of two novice observers, and secondly
to evaluate its validity as an outcome measure in terms of
its prediction of hospital length of stay (LOS).
Methods
The protocol was approved by the Local Research Ethics
Committee of York Hospital NHS Trust. A member of
the research team screened patients for eligibility, and
written informed consent was obtained from patients
prior to surgery. The study was performed in 2 parts, a
prospective analysis of the inter-rater agreement of the
POMS, and a retrospective analysis of data to assess its
validity.
Inter-rater agreement of the POMS
Inclusion criteria
Patients undergoing elective major abdominal surgery
defined as procedures expected to last more than 2
hours, or with an anticipated blood loss greater than 500
mL, were recruited. This included general surgery (colo-
rectal, pancreatic, gastric surgery), vascular surgery (ab-
dominal aortic aneurysm repair) and urological surgery
(cystectomy, prostatectomy and nephrectomy).
Protocol
Two independent and novice researchers, neither of
whom had used the POMS previously, visited patients
independently on postoperative day 1 and then daily
until hospital discharge. The researchers observed andquestioned the patient regarding the items defined in
the POMS (Table 1), and also reviewed patient notes,
charts and pathology results in order to complete the
POMS accurately.
Statistical analysis
Inter-rater reliability of the individual components of
the POMS (absence or presence of individual domain
morbidities) and the occurrence of any morbidity in
any domain was assessed using the κ coefficient, which
assesses agreement beyond that expected by chance alone.
Non-parametric data was analyzed using the Mann–
Whitney U-test. Incidences were calculated using the χ2
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analyzed by Fisher’s exact test, and strength of association
calculated. A P value less than 0.05 was considered signifi-
cant. Where appropriate 95% confidence intervals (CI)
were calculated. POMS domains that were significant on
univariate analysis were entered into a multivariate model
for further analysis.
Statistical analysis was performed with GraphPad Prism
ver. 5.0b for Mac OS X (GraphPad Software, San Diego,
CA, USA) and SPSS ver. 20.0 (SPSS Inc., Chicago, IL,
USA).
Validity of the POMS
From a secure research database (Microsoft Access,
Microsoft Corporation, Redmond, USA), patients who
had POMS assessments on day 3 and 5 postoperatively,
and who had undergone elective major abdominal
surgery meeting the inclusion criteria above, were identi-
fied. POMS data was then analyzed against hospital
LOS. This represents the criterion validity of the POMS,
with LOS being used as a surrogate for morbidity.
Results
Inter-rater agreement of the POMS
Fifty-one patients were recruited to the study giving a
total of 263 individual POMS assessments. Overall the
presence or absence of morbidity as defined by the
POMS showed a 97.7% agreement between observers,
with a κ coefficient of 0.912 (95% CI: 0.842 to 0.982),
giving near perfect agreement (Table 2).
The percentage agreements and κ coefficients for indi-
vidual POMS domain on days 1, 3, 5 and cumulatively,
are shown in Table 3. Overall percentage agreement was
high for the wound domain at 99.2%. However, there
was no evidence of agreement beyond that expected by
chance alone, and κ was estimated at near zero. Fair
agreement was seen in the hematological domain,
substantial agreement in the gastrointestinal and neuro-
logical domains, and almost perfect agreement in the
remaining 6 domains [6].
Validity of the POMS
POMS assessments were analyzed for postoperative day
3 (n = 258) and postoperative day 5 (n = 362) (Table 4).
This data was obtained from the prospective inter-rater
reliability study previously described, and three other
studies performed in the same institution in whichTable 2 Inter-rater correlation and percentage agreement of
POMS
Day 1 (n = 51) Day 2 (n = 51) Da
Percentage agreement (%) 100 100
κ correlation coefficient (95% CI) N/A 1.0 (1.0-1.0) 1
When observers scored all patients the same the hypothetical probability of chancePOMS data was prospectively obtained [7,8]. The me-
dian LOS for the cohort was 11 days (IQR: 8 to 15 days).
The absence or presence of morbidity measured by the
POMS was associated with a hospital LOS of 6 (IQR: 4
to 7) vs. 11 (IQR: 8 to 15) days when performed on
postoperative day 3 (P <0.0001), and 7 (IQR: 6 to 10) vs.
13 (IQR: 9 to 19) days when performed on postoperative
day 5 (P <0.0001). Kaplan-Meier analysis for the POMS
on postoperative days 3 and 5 and hospital LOS are
shown in Figure 1.
The incidence of morbidity in different domains for
postoperative days 3 and 5 are shown in Table 5, with
renal, pulmonary, gastrointestinal and pain morbidity
having the highest incidence on both days.
The relationship between morbidity in individual
domains on postoperative days 3 and 5, and median hos-
pital LOS is shown in Figures 2 and 3. On day 3, the
presence of morbidity in seven out of the nine domains
was associated with a longer hospital LOS, and on day 5
morbidity in all domains, with the exception of
hematological morbidity, was also associated with a
longer LOS. On multivariate regression analysis only the
presence of morbidity in the pulmonary domain on both
days 3 and 5 was statistically significant in explaining the
variations in hospital LOS (P <0.0001).
The presence of any morbidity on postoperative day 5
conferred an OR of 11.9 (95% CI: 5.02 to 28.31) for a
prolonged hospital LOS, defined as greater than the 3rd
interquartile for the cohort, but no predictive ability was
conferred to the same analysis on day 3 (OR: 3.64; 95%
CI: 0.83 to 15.92). ROC analysis by domain and day for
LOS is shown in Table 6, with significant differences
seen in the AUC on days 3 and 5 for the cardiovascular
and gastrointestinal domains.
POMS defined morbidity was absent in 9.7% of
patients on day 3 and 41.2% of patients on day 5 despite
them still receiving inpatient care.
Discussion
This study shows that the POMS is both a reliable and
valid measure of short-term postoperative morbidity in
patients undergoing major abdominal surgery. The main
strength of this paper is that it studies a homogenous
group of subjects all of whom underwent major abdom-
inal surgery, and hence could reliably be expected to
have a similar pattern of postoperative morbidity. The
study also examined the reliability of the survey whenthe presence or absence of morbidity as measured by the
y 3 (n = 51) Day 4 (n = 46) Day 5 (n = 40) Total (n = 263)
100 95.7 95 97.7
.0 (1.0-1.0) 0.873 (0.760-1.0) 0.895 (0.760-1.0) 0.912 (0.842-0.982)
could not be calculated, and are labeled N/A.
Table 3 Inter-rater correlation and percentage agreement for individual domains of the POMS on days 1, 3, 5 and cumulatively










Cardiovascular 94.1 0.876 (0.740-1.0) 100 1.0 (1.0-1.0) 97.5 0.655 (−0.012-1.0) 96.6 0.828 (0.718-
0.939)






Hematological 80.4 0.069 (−0.448-
0.587)
100 1.0 (1.0-1.0) 100 N/A 95.4 0.378 (0.035-
0.722)
Infectious 98.0 0.929 (0.793-1.0) 98.0 0.935 (0.810-1.0) 95.0 0.804 (0.539-1.0) 98.1 0.938 (0.884-
0.992)
Neurological 96.1 0.480 (−0.227-1.0) 96.1 0.779 (0.479-1.0) 97.5 0.655 (−0.012-1.0) 97.0 0.717 (0.524-
0.910)




Pulmonary 100 1.0 (1.0-1.0) 94.1 0.870 (0.727-1.0) 95.0 0.890 (0.742-1.0) 96.2 0.906 (0.852-
0.960)
Renal 98.0 0.658 (−0.007-1.0) 96.1 0.897 (0.757-1.0) 92.5 0.845 (0.677-1.0) 95.1 0.869 (0.802-
0.936)
Wound 98.0 0.0 (−1.0-1.0) 100 N/A 100 N/A 99.2 −0.004 (−1.0-1.0)


















Table 5 Incidence of morbidity by POMS domain on
postoperative days 3 and 5
Incidence of morbidity (%)










Table 4 Number and percentage of patients in each
surgical specialty analyzed in the assessment of the
validity of the POMS
Day 3 Day 5
n (%) n (%)
Colorectal 213 (82.6%) 260 (71.8%)
Vascular 8 (3.1%) 31 (8.6%)
Urology 35 (13.5%) 61 (16.8%)
Upper gastrointestinal 2 (0.8%) 10 (2.8%)
Total 258 362
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POMS, allowing an assessment of its potential use as an
outcome measure in both research and clinical practice,
where it would be required to be administered by a
spectrum of health professionals of varying experience.
Overall the inter-rater reliability of POMS-defined
morbidity showed high percentage agreement, and near
perfect correlation. Reliability within POMS domains
showed varying results, with the lowest percentage
agreement seen in the gastrointestinal domain, however
the κ correlation coefficient still showed a substantial
agreement. A similar result was also shown in the only
other validation of the POMS [9], in which the gastro-
intestinal domain showed the weakest correlationFigure 1 Kaplan-Meier curves for hospital LOS based upon the
presence or absence of POMS defined morbidity on
postoperative days 3 and 5.between observers, suggesting that the criteria may need
refining to give it greater clinical utility. In the study by
Grocott et al. [9] the majority of the items within the
POMS domains showed a perfect correlation, however
this was not the case in the present study. The reason
for the decreased correlation may be due to experienced
research nurses having administered the survey in the
previous work, whilst we chose specifically to assess the
reliability of the POMS when it was administered by
novices to its use. Despite this, POMS, as it currently
stands, could be used as an outcome measure without
specific training in its use.
There are a number of apparent discrepancies in the
reliability of individual domains as only fair correlation
was seen in the hematological domain, and no correl-
ation was seen in the wound domain despite good per-
centage agreement between observers. The use of the κ
coefficient in this setting unfairly describes the reliability
of the POMS as κ is affected by the prevalence of the
findings it is describing. When the reported prevalence
is low, as was the case in the hematological and wound
domains, then κ may not be a reliable measure of correl-
ation as illustrated by the high agreement but poor cor-
relation [10].
As the POMS cannot be used as a scale due to its low
internal consistency [9], the presence of any morbidity
recorded by the POMS must be associated with an
increased hospital LOS in order for it to be valid. The
presence of morbidity registered by the POMS at both
postoperative days 3 and 5 was associated with a longer
hospital LOS, and morbidity at day 5 was associated with
an eightfold increase in patients having a prolonged
hospital LOS (greater than the 3rd interquartile for the
cohort). These observations support the predictive ability
of the POMS, but also suggest additional utility for the
survey in the context of resource utilization due to its abil-
ity to predict those who will remain in hospital for longer.
Figure 2 Hospital LOS for the presence or absence of morbidity by individual POMS domain type on postoperative day 3. Data is
reported as median with interquartile range.
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presence of morbidity within 5 of the 9 domains was
associated with a longer hospital LOS; however, we
observed this in an additional 3 domains. This may re-
flect the significant differences in the two populations
studied, with the previous cohort consisting of almost
two thirds orthopedic patients undergoing peripheral
surgery, whilst this study contained a more homogenous
cohort all of whom underwent major abdominal surgery.
In addition, it also appears that a number of domains
are associated with a longer hospital LOS when the
POMS is administered earlier at postoperative day 3,
allowing a more prompt assessment of significant mor-
bidity that affects hospital LOS and strengthening its
validity as an outcome measure.
The pattern of morbidity seen in this study is similar
to that previously described [5,9], although higher
incidences of pain and pulmonary related morbidity, butlower incidences of gastrointestinal morbidity related
morbidity were seen. This is surprising given the nature
of the cohort, but a possible explanation for this reduc-
tion in gastrointestinal morbidity in a series that has
undergone major abdominal surgery may due to differences
in postoperative analgesia (epidural versus intravenous
opiates), or the adoption of enhanced recovery protocols
aimed at minimizing morbidity.
There are a number of limitations to this study, pri-
marily the small numbers in the reliability assessment of
the POMS; however, the overall number of observations
was acceptable. The cohort is not truly homogenous,
and although all subjects underwent major abdominal
surgery, the inclusion of vascular and urology patients,
who may have a different prevalence and pattern of mor-
bidity to those undergoing colorectal surgery, may limit
the application of results to this population. In addition
we did not assess patients with no POMS defined
Figure 3 Hospital LOS for the presence or absence of morbidity by individual POMS domain type on postoperative day 5. Data is
reported as median with interquartile range.
Davies et al. Perioperative Medicine 2013, 2:1 Page 7 of 9
http://www.perioperativemedicinejournal.com/content/2/1/1criteria for potentially important morbidity not captured
by the survey. It is possible that this group remained
hospitalized due to significant postoperative morbidity
rather than social issues or delays in the discharge
process. However, it has previously been observed that
patients remaining in hospital with no POMS defined
morbidity showed no evidence of any other morbidity
measured by different means [5,9].
There are also a number of limitations of the POMS itself
as many of the domains describe what is considered routine
therapy following major surgery (postoperative oxygen,
antibiotics, catheterization), however, by postoperative days
3 and 5, these routine therapies should have been ceased,
particularly in the context of enhanced recovery programs.
The lack of internal consistency of POMS, meaning that it
cannot be treated as a scale, only allows the POMS to iden-
tify the presence of morbidity but not to measure its sever-
ity, a tool that would be inherently useful when measuring
postoperative outcomes. Further modification of the POMSmay allow the development of a survey that measures a sin-
gle construct, and hence can be used to measure the sever-
ity of morbidity. The validity of the POMS in different and
specific surgical cohorts, for example vascular and urology,
also needs to be explored as the patterns of morbidity are
often different. However, it appears to be both valid and re-
liable in this group.
Accurate and meaningful reporting of outcomes in clin-
ical trials is essential; however, it has been acknowledged
that reporting of surgical adverse events in the health sys-
tem is inconsistent [11]. The underlying problem remains
the lack of standardization of reported outcome measures
in terms of timescale, the specific measurement, and the
definition of that same measurement. The standardization
of a core set of outcome measures would allow for more
effective comparison of interventions, allow appropri-
ate outcome measures to be collected and reported in
the correct way, aid meta-analysis and sample size
calculations, and simplify the design of trials for
Table 6 ROC analysis by POMS domain and postoperative
day measured for LOS
Domain Day AUC (95% CI) Z
Cardiovascular 3 0.69 (0.60-0.76) 2.699*
5 0.46 (0.29-0.60)
Gastrointestinal 3 0.70 (0.63-0.76) 2.355*
5 0.58 (0.50-0.65)
Hematological 3 0.70 (0.60-0.80) 0.307
5 0.65 (0.33-0.97)
Infectious 3 0.70 (0.62-0.78) 1.808
5 0.59 (0.50-0.68)
Neurological 3 0.60 (0.46-0.73) 1.311
5 0.73 (0.58-0.87)
Pain 3 0.73 (0.65-0.80) 1.863
5 0.63 (0.56-0.70)
Pulmonary 3 0.75 (0.69-0.81) 0.814
5 0.71 (0.65-0.76)
Renal 3 0.50 (0.42-0.57) 0.201
5 0.48 (0.40-0.57)
Wound 3 N/A N/A
5 0.52 (0.37-0.67)
*Statistically significant difference between the AUC.
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core outcome measures would be the reduction of out-
come reporting bias. Outcome reporting bias can be
defined as the selection for publication of a subset of
the originally reported outcome variables based on the
results [12].
The POMS is essentially a composite outcome meas-
ure, consisting of various domains in which those with
multiple items can be collapsed so that each domain
becomes a binary outcome. The primary outcome meas-
ure can then be considered a composite of the binary
outcomes for each domain. A composite outcome meas-
ure such as the POMS has a number of inherent
advantages over a single clinical endpoint, particularly in
clinical trials. Major complications as a core outcome
measure have a relatively low event rate; however, the
composite measure which combines outcomes increas-
ing the overall incidence of events, improves the power
of a study for a set number of participants, or reduces
the number of participants required to achieve a preset
power. The multi-component nature of composite
measures allows researchers the opportunity to be able
to describe the disease, or its process, more effectively,
particularly in complex states that affect multiple
systems such as the inflammatory response and the
associated morbidity following major abdominal surgery.
The components of a composite measure shoulddescribe the outcome of interest, and the POMS was
designed by clinicians to reflect clinically important
issues that caused patients to remain in hospital after
major surgery. Ideally the components should have simi-
lar frequency, treatment effects and severity [13,14],
however, this is practically difficult in complex disease
processes, and can be compensated for by modern stat-
istical methodology, which also allows not only an over-
all treatment effect to be detected from the composite,
but also the effect of the treatment on the individual
components [15].
Various statistical methodologies are available to clin-
ically utilize the POMS as a core outcome measure
following major abdominal surgery. The composite can
be collapsed to a single outcome; however, high fre-
quency items are then over-weighted at the expense of
less frequently occurring items that may be more clinic-
ally important. Alternatively, a count of events may be
employed; however, once again, this can be difficult to
interpret unless all events are of an equal severity. Multi-
variate generalized estimating equation (GEE) methods
[16,17] are less affected by issues of unequal severity and
frequency [15] and can be described in terms of a com-
mon effect GEE in which a treatment effect is estimated
across all components of the composite, or an average
relative effect GEE in which a treatment effect is estimated
for each component. In terms of the POMS as the com-
mon effect GEE methods are still biased by events that
occur with a higher frequency, a situation that arises in
this survey with the gastrointestinal and pain domains
having a high frequency, whereas morbidity in the wound
domain rarely occurs, the average relative effects GEE is
the more appropriate statistical tool to utilize as it
compensates for this effect. In addition clinically derived
weights for the importance of the various domains can be
applied to this model increasing its clinical utility,
although these must be assigned prior to data analysis.
Further work is required to simplify the POMS, and to
determine which domains and items have poor predict-
ive ability, allowing modification of the survey with add-
itional items with the view to constructing a survey that
has acceptable internal consistency, and hence can be
used as a scale. Additional consideration is also required
as to the potential of weighting individual domains based
on perceived clinical importance.Conclusions
The POMS is reliable, easy to use and shows predictive
validity when compared to hospital LOS, and also
predicts those subjects who will have a prolonged
hospitalization. It has the potential not only to be used
as a core outcome measure following major surgery, but
also as a tool to aid resource utilization.
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